<SEC-DOCUMENT>0001193125-17-033978.txt : 20170208
<SEC-HEADER>0001193125-17-033978.hdr.sgml : 20170208
<ACCEPTANCE-DATETIME>20170208090955
ACCESSION NUMBER:		0001193125-17-033978
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20170206
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20170208
DATE AS OF CHANGE:		20170208

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BAXTER INTERNATIONAL INC
		CENTRAL INDEX KEY:			0000010456
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				360781620
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-04448
		FILM NUMBER:		17581046

	BUSINESS ADDRESS:	
		STREET 1:		ONE BAXTER PKWY
		STREET 2:		DF2-1W
		CITY:			DEERFIELD
		STATE:			IL
		ZIP:			60015
		BUSINESS PHONE:		8479482000

	MAIL ADDRESS:	
		STREET 1:		ONE BAXTER PARKWAY
		STREET 2:		DF2-1W
		CITY:			DEERFIELD
		STATE:			IL
		ZIP:			60015

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BAXTER TRAVENOL LABORATORIES INC
		DATE OF NAME CHANGE:	19880522

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BAXTER LABORATORIES INC
		DATE OF NAME CHANGE:	19760608
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d328133d8k.htm
<DESCRIPTION>8-K
<TEXT>
<HTML><HEAD>
<TITLE>8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">8-K</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT
REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant to Section&nbsp;13 or 15(d) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported): February&nbsp;6, 2017 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Baxter International Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">1-4448</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">36-0781620</FONT></B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"><B>One Baxter Parkway, Deerfield, Illinois</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>60015</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"><B>(Address of principal executive offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(224) <FONT STYLE="white-space:nowrap">948-2000</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Registrant&#146;s telephone number, including area code) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Former name or former address, if changed since last report) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <FONT STYLE="white-space:nowrap">8-K</FONT> filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule <FONT STYLE="white-space:nowrap">14a-12</FONT> under the Exchange Act (17 CFR <FONT STYLE="white-space:nowrap">240.14a-12)</FONT> </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT STYLE="white-space:nowrap">14d-2(b)</FONT> under the Exchange Act (17 CFR 240.14d 2(b)) </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT STYLE="white-space:nowrap">13e-4(c)</FONT> under the Exchange Act (17 CFR
<FONT STYLE="white-space:nowrap">240.13e-4(c))</FONT> </TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain
Officers; Compensatory Arrangements of Certain Officers. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Election of Director </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Effective February&nbsp;6, 2017, Baxter International Inc. (the &#147;Company&#148;) appointed Dr.&nbsp;Stephen&nbsp;N. Oesterle to the
Company&#146;s board of directors (the &#147;Board&#148;). Dr.&nbsp;Oesterle was also appointed to the Board&#146;s Public Policy Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Oesterle will be compensated for service as a director pursuant to the Company&#146;s
<FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director Compensation Plan and will be eligible to participate in the Company&#146;s Directors&#146; Deferred Compensation Plan. In connection with joining the Board, Dr.&nbsp;Oesterle was granted
equity awards as compensation for a portion of his 2017 service (representing the period between his appointment date and the Company&#146;s 2017 Annual Meeting of Stockholders) in an amount consistent with the awards granted annually to <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors, prorated for the number of months to be served in accordance with the terms of the Company&#146;s <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director Compensation Plan. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B>Item&nbsp;8.01</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Other Events. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">On February&nbsp;8, 2017, the Company issued a press release announcing
the appointment of Dr.&nbsp;Oesterle to the Board. A copy of this press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Financial Statements and Exhibits. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Exhibits. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:23.50pt; font-size:8pt; font-family:Times New Roman">Exhibit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:81.20pt; font-size:8pt; font-family:Times New Roman">Description of Document</P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press Release of Baxter International Inc. dated February&nbsp;8, 2017</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: February&nbsp;8, 2017 </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">BAXTER INTERNATIONAL INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Ellen K. McIntosh</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Ellen K. McIntosh</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Corporate Vice President and Corporate Secretary</TD></TR>
</TABLE></DIV>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit Index </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Exhibit</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:26.20pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Number</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:37.25pt; font-size:8pt; font-family:Times New Roman">Description</P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press Release dated February&nbsp;8, 2017.</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d328133dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g328133img1.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>FOR IMMEDIATE RELEASE </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Media Contact: </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Bill Rader, (224) <FONT
STYLE="white-space:nowrap">948-5353</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor Contact: </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Clare Trachtman, (224) <FONT STYLE="white-space:nowrap">948-3085</FONT> </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BAXTER APPOINTS DR. STEPHEN OESTERLE TO ITS BOARD </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Industry Veteran Complements Current Board Expertise </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">DEERFIELD, Ill., February&nbsp;8, 2017 &#150; Baxter International Inc. (NYSE:BAX) today announced it has appointed Stephen (Steve) N.
Oesterle, M.D., to its Board of Directors, bringing the total number serving the company to 12. Dr.&nbsp;Oesterle now also serves on Baxter&#146;s Public Policy Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;We are excited to welcome Steve to Baxter&#146;s board,&#148; said Jos&eacute; (Joe) E. Almeida, chairman and chief executive officer.
&#147;His deep experience in leveraging technology to address global healthcare needs, coupled with his differentiated expertise as a former practicing physician, enhances our current board membership and supports our goals for patient-focused,
innovation-driven growth.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Oesterle is a consultant and provides advisory services to private equity and operating
companies in the healthcare industry. He previously served as senior vice president, Medicine and Technology at Medtronic and as a member of Medtronic&#146;s Executive Committee. He also held prior roles as associate professor of medicine and
director of Invasive Cardiology Services at Harvard Medical School-affiliated Massachusetts General Hospital, Stanford University </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>BAXTER APPOINTS DR. STEPHEN OESTERLE TO ITS BOARD &#150; Page 2 </U></B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Medical Center and Georgetown University Medical Center. Dr.&nbsp;Oesterle received his
bachelor&#146;s degree, <I>summa cum laude</I>, from Harvard University; his medical degree, <I>cum laude</I>, from Yale University School of Medicine; and conducted his residency at Massachusetts General Hospital. He completed a post-doctoral
fellowship in cardiology at Stanford University Medical Center. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Baxter provides a broad portfolio of essential renal and hospital
products, including home, acute and <FONT STYLE="white-space:nowrap">in-center</FONT> dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and
services. The company&#146;s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter&#146;s employees worldwide are building upon the
company&#146;s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">#
# # </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g328133img1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g328133img1.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ % !J P$1  (1 0,1 ?_$ +    ,! 0$
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M4*5!R4-!B** "H:BKM9^L/IA?R[*D.:-=JLQSE3R0I+BF&6TMRJ*E\1!)FD
M 5[23&RUTE]1U-FF8J1J=IFARM+2B%(0\ZM3D4A*8("@! K)) \ !XV<E</R
M^>/RU5OK3W)G=]0,C+>Z+%3FV[1DF>KIF]0I0N7MJ26JX6WQI5)&&/+UC8<!
M*I7ITQ:K<K4FHZ4%6B4RS9S<3.,QJ\LR^@+C]"[A/*Q6@VEP *+8<*PA:P%
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MM9J%4I, 74XM,</<"(!/TZ;^ZK^:[NC;ZDRFCJJ5JH#2JE8*EI2AO$>4!*0
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MA025!$\;@@*5QDBY)*H$@6HM^\+%VITIZ.-+&BJP,,8+<P*77">)VICT;2<
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MUW'>5YGX?+^DYN'ZY][Z?YCD.I8SG)<I-@8LHQ\;&XODQGFX<*>2^:S=V_\
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?[0=.FZ?R;.%-";#PTR32\,TL(RW1C"ZQO]85MJW_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
